Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
使用多阶段优化策略 (MOST) 为 HIV 临床护理中的吸烟者优化具有成本效益、可持续且可扩展的戒烟方案
基本信息
- 批准号:10649607
- 负责人:
- 金额:$ 65.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAcuteAddressAdministratorAffectBiochemicalCaringCause of DeathCessation of lifeClinicalCollaborationsCompetenceComplexConsolidated Framework for Implementation ResearchCost AnalysisCost MeasuresCounselingDataDecision AnalysisDiseaseEconomicsEffectivenessEffectiveness of InterventionsEvaluationFaceGeneral PopulationGoalsHIVHIV/AIDSHealthHealth PersonnelHealthcare SystemsHospitalsIndividualInternetInterventionIntervention TrialInterviewKnowledgeLifeLongitudinal StudiesMeasuresMedicalMethodsMotivationMunicipalitiesNational Cancer InstituteNew York CityNicotine WithdrawalOutcomePersonsPharmacotherapyPopulationPopulation HeterogeneityPrevalenceProcessProctor frameworkProfessional counselorPublic HealthReadinessResearchResourcesRiskServicesSmokerSmokingSmoking Cessation InterventionSocial supportStructureSurveysTestingText MessagingTimeTobaccoTobacco Use CessationWithdrawalbarrier to carecigarette smokingclinical carecomorbiditycostcost effectivecost effectivenesseffective therapyeffectiveness evaluationevidence baseimplementation interventionimplementation outcomesimplementation processimprovedinnovationinterestintervention costlong term abstinencemotivational enhancement therapymulti-component interventionmultiphase optimization strategynicotine replacementnon-smokerpatient-level barrierspeer coachingprematureprogramsrisk perceptionskillssmoking cessationsocial stigmatheoriesvarenicline
项目摘要
Project Summary
The adverse health impact of cigarette smoking on persons living with HIV is profound and effective treatments
for long-term abstinence remain elusive. There is an acute need for interventions that address patient barriers
to quitting and clinical barriers to effectively treating a broad heterogeneous population of smokers living with
HIV (SLWH). This study’s long-term goal is to improve clinical outcomes among SLWH by providing optimized
smoking cessation interventions in HIV clinical care. This proposal will use the Multiphase Optimization STrategy
(MOST) to test four intervention components aimed at barriers to quitting among SLWH, with the objective of
selecting the set that constitutes a cost-effective, sustainable, scalable smoking cessation package for HIV
clinical care. Components include: Motivational Interviewing (Off/On); Peer Mentoring (Off/On); Text-messaging
(Off/On); Varenicline or Combination Nicotine Replacement Therapy (Off/On). These components have shown
promise in research but are under-utilized to help SLWH quit and have not been tested in an optimization trial.
The proposed MOST factorial optimization trial is a highly efficient method for estimating the main effect
contribution of each intervention component and all interactions between components. This approach addresses
weaknesses in prior studies, which are not able to assess the contribution of individual components of
multicomponent interventions. The proposal will also include a rigorous evaluation of the implementation process
and theory-driven assessment of barriers to and facilitators of intervention implementation, sustainability and
scalability in HIV clinical care. Aims include: (1) Assess the effectiveness of four smoking cessation intervention
components on long-term abstinence among SLWH by conducting a highly efficient factorial optimization trial
(i.e., MOST) with 500 SLWH in HIV clinical care. (2) Assess costs and the implementation process, including
factors that affect the potential for sustainability and scalability of cessation treatment in HIV care settings serving
SLWH. Guided by Proctor’s Implementation Outcomes Framework and the Consolidated Framework for
Implementation Research, we will collect mixed methods data on reach, fidelity, acceptability and
appropriateness among SLWH, stakeholders and study interventionists. (3) Identify the optimized intervention
by conducting an innovative multi-criteria decision analysis to select the subset of the four components that
achieves the highest level of cost-effectiveness and is both scalable and sustainable in HIV clinical care. Working
in collaboration with New York City Health and Hospitals (H+H), the largest municipal public healthcare system
in the U.S., and a team with unparalleled expertise in intervention optimization, smoking cessation and HIV/AIDS,
the proposed study responds directly to the National Cancer Institute’s (NCI) call for smoking research that
“optimizes intervention effectiveness, implementation and sustainability.” The optimized intervention will have a
significant public health impact and add to scientific knowledge by providing a clear basis for further improvement
of cessation interventions for SLWH in future research.
项目摘要
吸烟对艾滋病毒感染者健康的不利影响是深刻和有效的治疗方法
长期禁欲的可能性仍然很小迫切需要解决患者障碍的干预措施
戒烟和临床障碍,以有效地治疗广泛的异质性吸烟人群,
艾滋病毒(SLWH)。本研究的长期目标是通过提供优化的治疗方案来改善SLWH的临床结局。
艾滋病毒临床护理中的戒烟干预措施。本提案将使用多阶段优化策略
(社会变革管理计划)测试四个干预组成部分,旨在消除SLWH中的戒烟障碍,目的是
选择一套构成一个具有成本效益的,可持续的,可扩展的艾滋病毒戒烟包
临床护理组件包括:动机面试(关/开);同伴指导(关/开);短信
(Off/开);伐尼克兰或联合尼古丁替代疗法(关/开)。这些组件显示
在研究中有希望,但未充分利用来帮助SLWH戒烟,并且尚未在优化试验中进行测试。
提出的MOST析因优化试验是一种高效的估计主效应的方法
每个干预组成部分的贡献和组成部分之间的所有互动。这种方法解决
以前的研究中的弱点,无法评估个别成分的贡献,
多元干预。该提案还将包括对执行过程的严格评估
和理论驱动的评估的障碍和促进因素的干预措施的实施,可持续性和
艾滋病临床护理的可扩展性。目的包括:(1)评估四种戒烟干预措施的效果
通过进行高效析因优化试验,
(i.e.,在艾滋病毒临床护理方面,有500名SLWH。(2)评估成本和实施过程,包括
影响艾滋病毒护理机构中戒烟治疗的可持续性和可扩展性的因素
SLWH。在普罗克特的执行成果框架和
实施研究,我们将收集混合方法数据的范围,保真度,可接受性和
SLWH、利益相关者和研究干预者之间的适当性。(3)确定优化的干预措施
通过进行创新的多标准决策分析来选择四个组成部分的子集,
实现了最高水平的成本效益,在艾滋病毒临床护理中既可扩展又可持续。工作
与纽约市卫生和医院(H+H)合作,这是最大的市政公共医疗保健系统
在美国,和一个在干预优化、戒烟和艾滋病毒/艾滋病方面拥有无与伦比的专业知识的团队,
这项研究直接响应了美国国家癌症研究所(NCI)对吸烟研究的呼吁,
“优化干预的有效性、实施和可持续性”。优化的干预措施将具有
对公众健康产生重大影响,并通过为进一步改进提供明确基础而增加科学知识
在未来的研究中对SLWH进行戒烟干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Cantrell其他文献
Jennifer Cantrell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Cantrell', 18)}}的其他基金
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
使用多阶段优化策略 (MOST) 为 HIV 临床护理中的吸烟者优化具有成本效益、可持续且可扩展的戒烟方案
- 批准号:
10548592 - 财政年份:2022
- 资助金额:
$ 65.05万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 65.05万 - 项目类别:
Standard Grant